The Scientist

» misconduct and microbiology

Most Recent

image: Week in Review: September 5–9

Week in Review: September 5–9

By | September 9, 2016

Environmental magnetite in the human brain; prion structure takes shape; watching E. coli evolve in real time; learning from others’ behavior 

0 Comments

image: Giant Petri Dish Displays Evolution in Space and Time

Giant Petri Dish Displays Evolution in Space and Time

By | September 8, 2016

As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.

7 Comments

image: Continued Fallout from Macchiarini Misconduct

Continued Fallout from Macchiarini Misconduct

By | September 7, 2016

The sacked researcher and surgeon was not properly vetted by the Swedish institutions that hired him in 2010, according to an independent review panel. 

0 Comments

image: Duke Sued for Millions over Fraudulent Data

Duke Sued for Millions over Fraudulent Data

By | September 6, 2016

A lawsuit claims that Duke University and biologist Erin Potts-Kant used bad data in projects funded by dozens of government grants.

2 Comments

image: Promoting Protein Partnerships

Promoting Protein Partnerships

By | September 1, 2016

Scientists generate new protein-protein interactions at an impressive PACE.

0 Comments

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

A former Mount Sinai School of Medicine faculty member shot the institution’s dean, The New York Times reports. 

0 Comments

image: Seven More Retractions for Cancer Researcher

Seven More Retractions for Cancer Researcher

By | August 10, 2016

All of the papers had been published in the Journal of Biological Chemistry.

1 Comment

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

Popular Now

  1. Next Generation: Mobile Microscope Detects DNA Sequences
  2. Scientists Activate Predatory Instinct in Mice
  3. Lipids Take the Lead in Metastasis
  4. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
RayBiotech